This Master's programme provides a comprehensive overview of drug safety practices within the drug development process.
To be admitted to the programme, applicants must have an undergraduate Honours qualification (minimum 2: 2) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields. Candidates who do not meet these entry criteria but who can show relevant experience may also be considered.
For North American students a GPA of normally 2.0 and above (on a scale of 4.0), or an equivalent, is required.
For fees and funding options, please visit website to find out more
The largest destination of our graduates is enrolment in PhD studies (47%) including here at Bradford, as well as King’s College London, Cambridge, Manchester, Liverpool, Leeds, Newcastle, Portsmouth and Sheffield.
Career destination of our graduates include the NHS, Covance, Envigo, St James Hospital Leeds, Cyprotex, Chiltern, Perrigo, Dewsbury & District Hospital, Liverpool Institute of Translational Medicine, and Public Health England.
First Year
Core
Preclinical Models for Drug Evaluation
Molecular Mechanisms of Toxicity
Case Studies in Drug Discovery
Cancer Therapeutics Research Project
Study a Postgraduate degree at Bradford Discover Master’s and taught courses at the University of Bradford What if this was your turning point? ...